Search Within

Department of Medicine

Formats
  1. Journal Article (19572)
  2. Meeting Abstract (16038)
  3. Review (1147)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22311)
  2. Hematologic Malignancies, Division of (13264)
  3. Center for Hematologic Malignancies (11049)
  4. GSK Faculty (10640)
  5. Survivorship Research (9323)
  6. Division of Subspecialty Medicine (7531)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1043)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3721)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6456)
  2. Elsevier Inc. (4213)
  3. American Society of Hematology (4000)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2109)

More Publishers

Results (39594)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes
    Research Letter

    Trněný, M.; Fogliatto, L.; Gardner, F.; Flinn, I.; Larouche, J. F.; Haioun, C.; Canales, M.; Goto, H.; Hajek, R.; Salles, G.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
    Journal Article

    Yisraeli Salman, M.; Terry, A. R.; Derkach, A.; Nemirovsky, D.; Chin, K. K.; Valtis, Y. K.; Boussi, L.; Spivey, T.; Xiao, W.; Famulare, C.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • AncestryGeni: A novel genetic ancestry classification pipeline for small and noisy sequence data
    Journal Article

    Elhaik, E.; Behnamian, S.; Howe, M.; Tang, H.; Yan, H.; Tian, S.; Shivaram, S.; Zepeda Mendoza, C.; MacLachlan, K.; Usmani, S.; more...
    Bioinformatics (2025)

    Fulltext@MSK | Save
  • Survival and patterns of failure in oligometastatic esophagogastric cancer
    Meeting Abstract

    Yariv, O.; Hilal, L.; Ku, G. Y.; Molena, D.; Janjigian, Y. Y.; Ilson, D. H.; Maron, S.; Sihag, S.; Strong, V. E.; Crane, C. H.; more...
    Radiotherapy and Oncology (2025)

    Fulltext@MSK | Save
  • ASCL1 and NEUROD1 are highly specific markers of lung vs digestive carcinoids/neuroendocrine tumors
    Meeting Abstract

    Willner, J.; Tarcan, Z.; Baine, M.; Armstrong, S.; Travis, W.; Wilson, C.; Bodd, F.; Tang, L.; Cooper, A.; Rudin, C.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Immunohistochemistry for the detection of STK11 (LKB1) genomic alterations in lung adenocarcinoma
    Meeting Abstract

    Saliba, M.; Febres-Aldana, C.; Baine, M.; Yang, S. R.; Sauter, J.; Travis, W.; Rudin, C.; Ladanyi, M.; Rekhtman, N.; Chang, J.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Integrated histological and molecular profiling of early-stage R0, resected non-mucinous lung adenocarcinomas
    Meeting Abstract

    Khan, I.; Aly, R. G.; Reiner, A.; Tan, K. S.; Rekhtman, N.; Chang, J.; Baine, M.; Chaft, J.; Travis, W.; Yang, S. R.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma
    Meeting Abstract

    Saliba, M.; Arfe, A.; Baine, M.; Bodd, F.; Chang, J.; Ortiz, E.; Wilson, C.; Linkov, I.; Mayoral, M.; Offin, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III-IV melanoma: Primary results from RELATIVITY-098
    Meeting Abstract

    Long, G. V.; Ascierto, P. A.; Guo, J.; Chandra, S.; Tarhini, A. A.; Couselo, E. M.; Del Vecchio, M.; De Melo, A. C.; Gogas, H.; Dummer, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304
    Meeting Abstract

    Rudin, C. M.; Mountzios, G. S.; Sun, L.; Cho, B. C.; Demirci, U.; Baka, S.; Gumus, M.; Lugini, A.; Ciuleanu, T. E.; Ahn, M. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save